|
| |
Image Results
Loading...
Loading...
Thrombotargets Development Pages on BioPortfolio:
|
Thrombotargets Corporation announces the incorporation of Steven ...
Durham, NC, June 1, 2007 – Thrombotargets Corp., a privately held group of Biotech Company focused in the discovery and development of innovative drugs,
...
http://www.bioportfolio.com/biotech_news/Thrombotargets_10.h...
|
Thrombotargets Corp. Announces the Membership of Its New ...
Durham, North Caroline, June 1, 2007 - Thrombotargets Corp., a privately owned biotech company focused on the development of new drug candidates and ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_6.ht...
|
Thrombotargets Corporation and Dr. Cam Patterson, Director of the ...
Thrombotargets ( www.thrombotargets.com ) is a privately held group of biotech companies focused on the discovery and development of innovative drugs in ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_11.h...
|
BioPortfolio BioCorporate Profile
Thrombotargets is an innovative drug discovery and development group of biotech companies developing new medicines based on advances in recombinant DNA and ...
http://www.bioportfolio.com/biocorporate/pdf/31064/thrombota...
|
BioPortfolio - Thrombotargets Europe S.L. - Profile
View the current Thrombotargets Europe S.L. Page on BioPortfolio.com ... NeurAxon, Inc. to Present at Upcoming Investor and Business Development
Conferences ...
http://www.bioportfolio.com/biocorporate/36215-Thrombotarget...
|
BioPortfolio Biotechnology and Pharmaceutical News April to June 2007
Protagen expands Supervisory Board to support the development and ... Thrombotargets inaugurates new facilities at the National Biotechnology Centre (
CNB) ...
http://www.bioportfolio.com/biotech_news/april_to_june_2007....
|
BioPortfolio Biotechnology and Pharmaceutical News July to ...
Prosarix and ChemOvation enter into co-development and licensing agreement ... Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on ...
http://www.bioportfolio.com/biotech_news/july_to_september_2...
| Results from other life science and pharmaceutical sites:
BioSpace - Thrombotargets Corporation News, Search Jobs, Events
Thrombotargets is an innovative drug discovery and development group of biotech companies developing new medicines based on advances in recombinant DNA and ...
http://www.biospace.com/company_profile.aspx?CompanyId=10034...
|
DOCUMENT CS 1/04 2008
Premis Barcelona 2007, atorgat a l'empresa Thrombotargets Europe, ... de la Cātedra UNESCO de Sostenibilitat, per la seva tesi doctoral “Human development
...
http://www.upc.edu/bupc/hemeroteca/2008/b105/consellsocial/0...
|
Bleeding - Biotech, Clinical Research, Pharmaceutical News & Jobs
Thrombotargets Corporation Announced it has submitted its Orphan Drug .... Will Stop Further Development Of Its Interferon Beta Program 12/6/2004 More. ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...
|
List of Orphan Products Designa - US Food and Drug Administration ...
8/19/03, Pfizer Global Research and Development, 50 Pequot Avenue ...... 10/11/ 07, Thrombotargets Corp. 2530 Meridian Parkway, Durham NC 27713 ...
http://www.fda.gov/downloads/forindustry/developingproductsf...
|
BioSpace Life Sciences Company Profiles by Industry Segment
Services - Real Estate/Development, Laboratory Building/Design · Services - Regulatory Consulting · Services - Research ..... Faustus Forschung
Translational Drug Development AG · Faustus Forschungs Cie. ..... Thrombotargets
Corporation ...
http://www.biospace.com/company_segment.aspx?SegmentId=38919...
|
|
